Abstract
ObjectivesThe aim of this study is to investigate the interference of carbamylated haemoglobin (cHb) to haemoglobin A1c (HbA1c) measurements in patients with chronic kidney disease (CKD) by three ion-exchange chromatography methods. Design and methodsWe included three ion-exchange chromatography methods (Bio-Rad Variant II, G7 and HA-8160) and one affinity chromatography method (Primus Ultra2) to test HbA1c. In vitro carbamylation of haemoglobin was also performed to test interference of carbamylation. Results152 CKD patients were diagnosed. The average HbA1c and urea levels of nondiabetic and diabetic patients were 5.24% (33.8mmol/mol) and 7.36% (56.9mmol/mol) and 16.2mmol/L and 11.2mmol/L, respectively. Repeated measures ANOVA showed that the difference of HbA1c values between four methods is not statistically significant (P=0.421 for non-DM and P=0.336 for DM). With the increase in blood urea concentration from stage 3 to stage 5, there was no corresponding increase in HbA1c values for both groups. In vitro carbamylation results showed that carbamylated Hb peaks could be clearly identified by the three ion-exchange methods. ConclusionHbA1c measurement by these methods may not be impacted by carbamylated Hb. The results should be interpreted with caution in high carbamylated Hb patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
